ASX set to edge up, Wall Street advances after US-Japan trade deal; $A stronger
The S&P 500 was 0.5 per cent higher, coming off its latest all-time high. The Dow Jones was up 431 points, or 1 per cent, in mid-afternoon trade, and the Nasdaq composite was 0.3 per cent higher. The Australian sharemarket is set to inch higher, with futures at 5.03am AEST pointing to a rise of 6 points, or 0.1 per cent, at the open. The ASX added 0.7 per cent on Wednesday.
The Australian dollar was 0.7 per cent higher at 66.01 US cents at 5.18am.
Stocks jumped even more in Tokyo, where the Nikkei 225 rallied 3.5 per cent after President Donald Trump announced a trade framework that would place a 15 per cent tax on imports coming from Japan. That's lower than the 25 per cent rate that Trump had earlier said would kick in on August 1.
'It's a sign of the times that markets would cheer 15 per cent tariffs,' said Brian Jacobsen, chief economist at Annex Wealth Management. 'A year ago, that level of tariffs would be shocking. Today, we breathe a sigh of relief.'
Loading
Trump has proposed stiff taxes on imports from around the world, which carry the double-edged risk of driving up inflation for US households while slowing the economy. But many of Trump's tariffs are currently on pause, giving time to reach deals with other countries that could lower the tax rates. Trump also announced a trade agreement with the Philippines on Tuesday.
So far, the US economy has seemed to hold up OK despite the pressures on it. And tariffs already in place may be having less of an effect than expected, at least when it comes to the prices that US households are paying at the moment.
'The main lesson about tariffs so far is that passthrough to consumer prices is tracking somewhat lower than in 2019,' according to Goldman Sachs economist David Mericle.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
AU Financial Review
40 minutes ago
- AU Financial Review
US reaches new trade deal with European Union
Global pharmaceutical giants, including Pfizer and Johnson & Johnson, are paying a tiny fraction of the billions of dollars they earn from drug sales in local taxes, at a time when they're lobbying US President Donald Trump to force an overhaul of Australia's Pharmaceutical Benefits Scheme. An analysis of earnings statements filed with the corporate regulator by five of the biggest US and European drugmakers shows the companies on average pay between 2 per cent and 4 per cent of their Australian sales in income tax. The numbers may make for uncomfortable reading for drug multinationals as they step up efforts to loosen the PBS' grip on the pricing of key medicines.
AU Financial Review
40 minutes ago
- AU Financial Review
ASX set for modest dip; US-China tipped to extend trade truce
Equity markets are staring down a high-stakes week, with earnings season, key inflation data and a US Federal Reserve meeting all on the radar – and plenty of scope for volatility as the ASX hovers near record highs. Local futures are pointing to a modest dip at Monday's open, even after Wall Street pushed higher again, with the S&P 500 notching its fifth consecutive record close. The Fed's interest rate decision, due Friday morning AEST, is likely to set the tone. While no change is expected, Chair Jerome Powell's remarks will be closely parsed for hints of a potential September cut — especially with economic data showing mixed signals. Non-farm payrolls and the central bank's preferred inflation measure are also due this week. Back home, Rio Tinto kicks off earnings season, while Wednesday's CPI report looms large. The Reserve Bank has flagged that any policy shift hinges on fresh inflation data, and a soft enough read could pave the way for a rate cut in August. Westpac expects headline inflation to come in at 0.9 per cent for the June quarter, or 2.3 per cent annually. The RBA's preferred trimmed mean is tipped to rise 0.7 per cent, to an annual pace of 2.7 per cent. With global equities on a tear and the ASX just 1 per cent shy of its own all-time high, some strategists are starting to question how far this rally can run. 'Bubble is a big word, but the notion that the sharemarket is egregiously overvalued is one that I am sympathetic to,' said GSFM's Stephen Miller. 'These things can go on for a while, but markets have a tendency to walk up the stairs and down the elevator shaft. But I think there comes a time, too, when people like me who have been defensive haven't got that right, yet.'
ABC News
40 minutes ago
- ABC News
Live updates: US and EU seal trade deal, Wall St has fifth record close, ASX response looks muted
The US and EU have just completed a trade deal that will impose a 15 per cent tax on European imports into the US. The deal, described by US President Donald Trump as "the biggest ever made", mirrors a recent deal with Japan, which was also threatened with a much higher tax but settled for less. EU President Ursula von der Leyen said the deal would bring "stability". Meanwhile, a combination of solid corporate results and optimism about the US signing more trade deals before the August 1 "deadline" propelled Wall Street's S&P 500 and Nasdaq indices to record closes on Friday. The ASX response looks muted, with futures markets pointing to a marginal 0.1 per cent decline opening, ahead of Wednesday's important inflation figures. Follow the day's financial news and insights from our specialist business reporters on our live blog. Disclaimer: this blog is not intended as investment advice.
